Interaction of growth factors during progression towards steroid independence in T‐47‐D human breast cancer cells

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Cellular Biochemistry

• Publication date

  1990-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcb.240430302PMID 2199468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological differences among MCF-7 human breast cancer cell lines from different laboratories

  2005cited by this paper
• Cold spring harbor.

  1991cited by this paper
• The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.

  1989cited by this paper
• Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells.

  1989cited by this paper
• Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

  1989cited by this paper
• Regulation of Transforming Growth Factor α and Transforming Growth Factor β Messenger Ribonucleic Acid Abundance in T-47D, Human Breast Cancer Cells

  1989cited by this paper
• Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line.

  1989cited by this paper
• Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D.

  1988cited by this paper
• Epidermal growth factor receptors in human breast cancer.

  1988cited by this paper
• Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas.

  1988cited by this paper
• Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.

  1988cited by this paper
• Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.

  1988cited by this paper
• Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.

  1988cited by this paper
• Peptide growth factors are multifunctional

  1988cited by this paper
• Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells

  1988cited by this paper
• Mitogenic stimulation of human breast cancer cells in a growth factor‐defined medium: Synergistic action of insulin and estrogen

  1988cited by this paper
• Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.

  1988cited by this paper
• Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model

  1988cited by this paper
• Insulin-like growth factor II mRNA expression in human breast cancer.

  1988cited by this paper
• Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells.

  1988cited by this paper
• Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer.

  1988cited by this paper
• Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growth.

  1987cited by this paper
• Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.

  1987cited by this paper
• Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.

  1987cited by this paper
• CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements

  1987cited by this paper
• Some recent advances in the chemistry and biology of transforming growth factor-beta

  1987cited by this paper
• Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.

  1987cited by this paper
• Expression of transforming growth factor alpha (TGF alpha) in differentiated rat mammary tumors: estrogen induction of TGF alpha production.

  1987cited by this paper
• Progression to steroid insensitivity can occur irrespective of the presence of functional steroid receptors.

  1987cited by this paper
• Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture.

  1987cited by this paper
• Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.

  1987cited by this paper
• Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.

  1987cited by this paper
• Growth regulation of human breast carcinoma occurs through regulated growth factor secretion

  1987cited by this paper
• Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture.

  1986cited by this paper
• Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells.

  1986cited by this paper
• A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells.

  1986cited by this paper
• Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.

  1986cited by this paper
• Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells

  1985cited by this paper
• Type beta transforming growth factor: a bifunctional regulator of cellular growth.

  1985cited by this paper
• Transfection of v-rasH DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity.

  1985cited by this paper
• Bacterial beta-galactosidase as a marker of Rous sarcoma virus gene expression and replication

  1985cited by this paper
• Progression to steroid autonomy in S115 mouse mammary tumor cells: role of DNA methylation

  1984cited by this paper
• Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7.

  1984cited by this paper
• Effect of estradiol on human breast cancer cells in culture.

  1983cited by this paper
• Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

  1982cited by this paper
• Cancer of the breast: the past decade (first of two parts).

  1980cited by this paper
• Establishment and characterization of a cell line of human breast carcinoma origin.

  1979cited by this paper
• DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

  1979cited by this paper
• Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

  1978cited by this paper
• HANDBOOK OF EXPERIMENTAL PHARMACOLOGY

  1969cited by this paper
• Textbook of Endocrinology

  1956cited by this paper

• Endocrine Disruptors Leading to Obesity and Related Diseases

  2017cites this paper
• Genotoxicity of cosmetic chemicals in human breast epithelial cells

  2016cites this paper
• Molecular mechanisms of oestrogen action on growth of human breast cancer cells in culture

  2012cites this paper
• Enhanced sensitivity to rapamycin following long-term oestrogen deprivation in MCF-7, T-47-D and ZR-75-1 human breast cancer cells.

  2011cites this paper
• Crosstalk with insulin and dependence on PI3K/Akt/mTOR rather than MAPK pathways in upregulation of basal growth following long-term oestrogen deprivation in three human breast cancer cell lines

  2011cites this paper
• BCL-2 family function in antiestrogen-resistant breast cancer cells

  2009cites this paper
• by High and Low Metastatic Variants of B 16 BL 6 Melanoma Differential Growth Factor Production , Secretion , and Response Updated

  2006cites this paper
• Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells

  2006cites this paper
• The multifunctional role of transforming growth factor (TGF)-ßs on mammary epithelial cell biology

  2005cites this paper
• Adaptation of Estrogen-regulated Genes in Long-term Estradiol Deprived MCF-7 Breast Cancer Cells

  2005cites this paper
• Resistance to Transforming Growth Factor 1 and Activin Due to Reduced Receptor Expression in Human Breast Tumor Cell Lines ’

  2005cites this paper
• IGF-I and IGF-II expression in human breast cancer xenografts: Relationship to hormone independence

  2005cites this paper
• Tumor-suppressive and promoting function of transforming growth factor beta.

  2004cites this paper
• Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy.

  2004cites this paper
• Mechanisms of hormone resistance in breast cancer

  2004cites this paper
• Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells.

  2002cites this paper
• Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.

  2002cites this paper
• Oestrogenic activity of parabens in MCF7 human breast cancer cells.

  2002cites this paper
• Autocrine TGFβ supports growth and survival of human breast cancer MDA-MB-231 cells

  2002cites this paper
• Role of insulin‐like growth factor binding protein‐3 in breast cancer cell growth

  2002cites this paper
• Homeostasis of extracellular matrix by TGF-beta and lefty.

  2002cites this paper
• Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-β (TGF-β) and the Type II TGF-β Receptor*

  2000cites this paper
• Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.

  2000cites this paper
• Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid

  2000influential citation
• Sex hormone-induced mammary carcinogenesis in female Noble rats: expression of TGF-beta1 and its receptors, TGF-alpha, and EGF-R in mammary carcinogenesis.

  1999cites this paper
• Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

  1999cites this paper
• Sex hormone-induced mammary carcinogenesis in female Noble rats: Expression of TGF-β1 and its receptors, TGF-α, and EGF-R in mammary carcinogenesis

  1999cites this paper
• Overexpression of insulin‐like growth factor II (IGFII) in ZR‐75‐1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression

  1999cites this paper
• Transforming Growth Factor-β and Breast Cancer

  1999cites this paper
• Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.

  1999cites this paper
• ALTERED PHENOTYPIC CHARACTERISTICS OF T47D HUMAN BREAST CANCER CELLS AFTER PROLONGED GROWTH IN ESTROGEN‐DEFICIENT MEDIUM

  1998cites this paper
• Growth inhibitors for mammary epithelial cells.

  1998cites this paper
• The Role of Transforming Growth Factor-β in the Regulation of Estrogen Receptor Expression in the MCF-7 Breast Cancer Cell Line.

  1997cites this paper
• 3,5,3',5'-tetrachlorobiphenyl is a weak oestrogen agonist in vitro and in vivo.

  1997cites this paper
• The role of transforming growth factor-beta in the regulation of estrogen receptor expression in the MCF-7 breast cancer cell line.

  1997cites this paper
• Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.

  1997cites this paper
• Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells.

  1997cites this paper
• 7 – Mammary stem cells in normal development and cancer

  1997cites this paper
• Growth factors and cytokines in health and disease: Breast cancer

  1997cites this paper
• Expression of Transforming Growth Factor β Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells*

  1997cites this paper
• Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor-reporter gene assays.

  1996cites this paper
• Isolation and characterization of variant benzo[a]pyrene‐resistant T47D human breast‐cancer cells

  1996cites this paper
• Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily.

  1996cites this paper
• Growth Factors and Modulation of Endocrine Response in Breast Cancer

  1996cites this paper
• 3,4,3',4'-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo.

  1996cites this paper
• Inhibition of stilbene estrogen-induced cell proliferation of renal epithelial cells through the modulation of insulin-like growth factor-I receptor expression.

  1996cites this paper
• Complex role of tumor cell transforming growth factor (TGF)-βs on breast carcinoma progression

  1996cites this paper
• An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein.

  1995cites this paper
• Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines.

  1995cites this paper
• Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response.

  1995cites this paper
• How do breast cancers become hormone resistant?

  1994cites this paper
• Why are Steroid Receptor Antagonists Sometimes Agonists

  1994cites this paper
• Hormone 'resistance' in breast cancer: the role of normal and mutant steroid receptors.

  1994cites this paper
• Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.

  1994cites this paper
• Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants.

  1994cites this paper
• High passage T47D human breast cancer cells: altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness.

  1994cites this paper
• Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma.

  1993cites this paper
• Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.

  1993cites this paper
• Can Hormone “Resistant” Breast Cancer Cells Be Inappropriately Stimulated by Tamoxifen? a

  1993cites this paper
• Evidence for a positive role of transforming growth factor‐β in human breast cancer cell tumorigenesis

  1993cites this paper
• Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

  1993cites this paper
• Basic fibroblast growth factor (bFGF): mitogenic activity and binding sites in human breast cancer.

  1992cites this paper
• Transforming growth factor-beta isoforms in mammary neoplasia: more questions than answers.

  1992cites this paper
• Heterogeneity of progesterone receptor content and remodeling by tamoxifen characterize subpopulations of cultured human breast cancer cells: analysis by quantitative dual parameter flow cytometry.

  1992cites this paper
• Roles for transforming growth factors-beta in the genesis, prevention, and treatment of breast cancer.

  1992cites this paper
• Cellular heterogeneity and mutant oestrogen receptors in hormone resistant breast cancer.

  1992cites this paper
• Progression from steroid sensitive to insensitive state in breast tumours.

  1992cites this paper
• Transforming growth factor-β isoforms in mammary neoplasia: More questions than answers

  1992cites this paper
• [FGFB binding sites in cancers of the human breast].

  1992cites this paper
• Tissue culture conditions determine the effects of estrogen and growth factors on the anchorage independent growth of human breast cancer cell lines.

  1991cites this paper
• Demonstration of basic fibroblast growth factor high and low affinity binding sites in human breast cancer cell lines.

  1991cites this paper
• Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.

  1991cites this paper
• 6. Steroids and steroid receptors in growth control of cultured breast cancer cells

  1990cites this paper
• 5. Human breast‐cancer growth and progression: Role of secreted polypeptide growth factors

  1990cites this paper
• Steroids and steroid receptors in growth control of cultured breast cancer cells.

  1990cites this paper
• Transition of human breast cancer cells from an oestrogen responsive to unresponsive state.

  1990cites this paper
• Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.

  1990cites this paper
• Approaches to studying the role of growth factors in the progression of breast tumours from the steroid sensitive to insensitive state.

  1989cites this paper